Macrolide Antibiotics Global Market 2024 - By Demand, Share, Size, Trends, Forecast To 2033

The macrolide antibiotics market size is expected to see rapid growth in the next few years. It will grow to $91.64 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%.  The growth in the forecast period can be attributed to a rise in respiratory infections due to factors like arise in respiratory infections, rise in combination therapies, an increase in the global geriatric population, increased awareness and diagnostics, and growth in telemedicine and online pharmacy services. Major trends in the forecast period include advancements in drug delivery systems and formulations, the development of novel macrolide antibiotics, advancements in telemedicine and remote healthcare services, and the development of eco-friendly manufacturing processes for macrolide antibiotics.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/macrolide-antibiotics-global-market-report

Segmentation & Regional Insights
The macrolide antibiotics market covered in this report is segmented –
1) By Drugs: Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Telithromycin
2) By Indication: Respiratory Tract Infections, Skin Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Other Indications
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
5) By End User: Hospital, Dermatology Clinic, Clinic, Ambulatory Centre, Research Laboratories

North America was the largest region in the macrolide antibiotics market in 2023. The regions covered in the macrolide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16472&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of skin infections is expected to propel the growth of the macrolide antibiotics market going forward. A skin infection is a condition caused by the invasion of harmful microorganisms into the skin, leading to inflammation and often accompanied by symptoms such as redness, swelling, and pain. Growing skin infections may result from factors such as poor hygiene practices, compromised immune systems, exposure to environmental pollutants, antibiotic resistance, and inadequate wound care. Macrolide antibiotics are often prescribed for treating skin infections caused by bacteria such as Staphylococcus aureus or Streptococcus pyogenes, particularly in cases of penicillin allergy or resistance. For instance, in September 2022, according to the UK Health Security Agency (UKHSA), a UK-based national executive agency, the percentage of Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia cases attributed to skin and soft tissue infections rose from 25.7% in the financial year April 2020 to March 2021 to 33.7% in the financial year April 2021 to March 2022. Similarly, for Methicillin-Sensitive Staphylococcus aureus (MSSA) bacteremia cases, the percentage increased from 27.2% to 28.5% over the same period. Therefore, the increasing prevalence of skin infections is driving the growth of the macrolide antibiotics market.

Key Industry Players
Major companies operating in the macrolide antibiotics market are Pfizer Inc., Roche Holding AG, Merck Sharp & Dohme Corp, AbbVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Eli Lily and Company, Amgen Inc., Teva Pharmaceutical Industries Limited, Mylan N.V., Daiichi Sankyō, Sun Pharmaceutical Industries Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Zhejiang Guobang Pharmaceutical Co. Ltd., Fresenius Kabi USA, WOCKHARDT, Crescent Pharma Limited, Wellona Pharma Private Limited

The macrolide antibiotics market report table of contents includes:
1. Executive Summary
2. Macrolide Antibiotics Market Characteristics
3. Macrolide Antibiotics Market Trends And Strategies
4. Macrolide Antibiotics Market - Macro Economic Scenario
5. Global Macrolide Antibiotics Market Size and Growth
.....................................
32. Global Macrolide Antibiotics Market Competitive Benchmarking
33. Global Macrolide Antibiotics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Macrolide Antibiotics Market
35. Macrolide Antibiotics Market Future Outlook and Potential Analysis
36. Appendix

Explore the trending research reports from TBRC:
https://goodprnews.com/advanced-tires-global-market-size/
https://goodprnews.com/agm-batteries-for-cars-global-market-size/
https://goodprnews.com/air-pressure-sensors-global-market-size/
https://topprnews.com/advanced-tires-global-market-share/
https://topprnews.com/agm-batteries-for-cars-global-market-share/
https://topprnews.com/air-pressure-sensors-global-market-share/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model